DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication
Artículo científico (JournalArticle)
Investigation of nanoparticle extravasation pathways in tumor vessel-on-a-chip devices
14 pages, 9 figures, The pathways through which nanomedicines extravasate from the bloodstream into solid tumors remain a subject of active investigation. To elucidate this process, we examine the predominant transport mechanisms in vitro using a tumor-vessel-on-chip (TVoC) microfluidic model device. The device comprises a micro-vessel lined with human umbilical vein endothelial cells, positioned adjacent to a compartment containing a collagen-based extracellular matrix. The two compartments are separated by a row of micropillars, where an endothelial barrier naturally forms at the interface within the gaps. Here, transport of different nanoparticles is analyzed under simulated vascular flow conditions. Strengthening endothelial cell junctions to modulate barrier properties led to a nearly 50 % reduction in the permeability coefficient. Furthermore, disruption of intracellular pathways resulted in minimal nanoparticle permeability, which is consistent with the interpretation that the tested nanoparticles predominantly extravasate via the interendothelial route., A.M.A. acknowledges a predoctoral scholarship from the Severo Ochoa Program for Centers of Excellence in R&D (grant no: PRE2019- 88686) of the Spanish Ministry of Science and Innovation. This research was carried out with funding from the EVONANO project funded by the European Union’s Horizon 2020 FET Open program (Grant agreement No. 800983), and from funding from Spanish Ministry of Science and Innovation (grant No. PID2020-120202RB-I00). IMDEA Nanoscience receives support from the ‘Severo Ochoa’ Programme for Centers of Excellence in R&D (Spanish Ministry of Science and Innovation Grant No. CEX2020-001039-S).